These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 11258401
1. The optimal imaging time for [99Tcm]TRODAT-1/SPET in normal subjects and patients with Parkinson's disease. Kao PF, Tzen KY, Yen TC, Lu CS, Weng YH, Wey SP, Ting G. Nucl Med Commun; 2001 Feb; 22(2):151-4. PubMed ID: 11258401 [Abstract] [Full Text] [Related]
2. Imaging of dopamine transporters with technetium-99m TRODAT-1 and single photon emission computed tomography. Bao SY, Wu JC, Luo WF, Fang P, Liu ZL, Tang J. J Neuroimaging; 2000 Oct; 10(4):200-3. PubMed ID: 11147397 [Abstract] [Full Text] [Related]
3. 99mTc-TRODAT-1 imaging of multiple system atrophy. Lu CS, Weng YH, Chen MC, Chen RS, Tzen KY, Wey SP, Ting G, Chang HC, Yen TC. J Nucl Med; 2004 Jan; 45(1):49-55. PubMed ID: 14734673 [Abstract] [Full Text] [Related]
4. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects. Weng YH, Yen TC, Chen MC, Kao PF, Tzen KY, Chen RS, Wey SP, Ting G, Lu CS. J Nucl Med; 2004 Mar; 45(3):393-401. PubMed ID: 15001678 [Abstract] [Full Text] [Related]
5. Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease. Swanson RL, Newberg AB, Acton PD, Siderowf A, Wintering N, Alavi A, Mozley PD, Plossl K, Udeshi M, Hurtig H. Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):302-7. PubMed ID: 15791439 [Abstract] [Full Text] [Related]
6. Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers. Mozley PD, Schneider JS, Acton PD, Plössl K, Stern MB, Siderowf A, Leopold NA, Li PY, Alavi A, Kung HF. J Nucl Med; 2000 Apr; 41(4):584-9. PubMed ID: 10768556 [Abstract] [Full Text] [Related]
7. Investigating the role of 99mTc-TRODAT-1 SPECT imaging in idiopathic Parkinson's disease. Geng Y, Shi GH, Jiang Y, Xu LX, Hu XY, Shao YQ. J Zhejiang Univ Sci B; 2005 Jan; 6(1):22-7. PubMed ID: 15593387 [Abstract] [Full Text] [Related]
8. Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats. Dresel SH, Kung MP, Plössl K, Meegalla SK, Kung HF. Eur J Nucl Med; 1998 Jan; 25(1):31-9. PubMed ID: 9396872 [Abstract] [Full Text] [Related]
9. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease. Lynch DR, Mozley PD, Sokol S, Maas NM, Balcer LJ, Siderowf AD. Mov Disord; 2003 Jul; 18(7):804-12. PubMed ID: 12815660 [Abstract] [Full Text] [Related]
10. Single photon emission computer tomography of dopamine transporters in monkeys and humans with 99mTc-TRODAT-1. Hu P, Chen L, Zhang HQ, Li JR, Liang H. Chin Med J (Engl); 2004 Jul; 117(7):1056-9. PubMed ID: 15265382 [Abstract] [Full Text] [Related]
11. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease. Hwang WJ, Yao WJ, Wey SP, Ting G. J Nucl Med; 2004 Feb; 45(2):207-13. PubMed ID: 14960637 [Abstract] [Full Text] [Related]
13. Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters. Mozley PD, Stubbs JB, Plössl K, Dresel SH, Barraclough ED, Alavi A, Araujo LI, Kung HF. J Nucl Med; 1998 Dec; 39(12):2069-76. PubMed ID: 9867143 [Abstract] [Full Text] [Related]
14. Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1. Tzen KY, Lu CS, Yen TC, Wey SP, Ting G. J Nucl Med; 2001 Mar; 42(3):408-13. PubMed ID: 11337515 [Abstract] [Full Text] [Related]
15. In vivo imaging of serotonin transporters with [99mTc]TRODAT-1 in nonhuman primates. Dresel SH, Kung MP, Huang X, Plössl K, Hou C, Shiue CY, Karp J, Kung HF. Eur J Nucl Med; 1999 Apr; 26(4):342-7. PubMed ID: 10199939 [Abstract] [Full Text] [Related]
16. Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients. Hsiao IT, Weng YH, Lin WY, Hsieh CJ, Wey SP, Yen TC, Kung MP, Lu CS, Lin KJ. Nucl Med Biol; 2014 Apr; 41(4):322-9. PubMed ID: 24503330 [Abstract] [Full Text] [Related]
17. Imaging early-stage corticobasal degeneration with [99mTc]TRODAT-1 SPET. Lai SC, Weng YH, Yen TC, Tsai CC, Chang HC, Wey SP, Ting G, Lu CS. Nucl Med Commun; 2004 Apr; 25(4):339-45. PubMed ID: 15097807 [Abstract] [Full Text] [Related]
18. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Booij J, Speelman JD, Horstink MW, Wolters EC. Eur J Nucl Med; 2001 Mar; 28(3):266-72. PubMed ID: 11315592 [Abstract] [Full Text] [Related]
19. Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography. Tatsch K, Schwarz J, Mozley PD, Linke R, Pogarell O, Oertel WH, Fieber RS, Hahn K, Kung HF. Eur J Nucl Med; 1997 Apr; 24(4):415-21. PubMed ID: 9096093 [Abstract] [Full Text] [Related]
20. Logistic discriminant parametric mapping: a novel method for the pixel-based differential diagnosis of Parkinson's disease. Acton PD, Mozley PD, Kung HF. Eur J Nucl Med; 1999 Nov; 26(11):1413-23. PubMed ID: 10552082 [Abstract] [Full Text] [Related] Page: [Next] [New Search]